Medication
Ended Awarded Last action
- Contract number
- 36C24622N0542
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,426
Award facts
- Contract value 100% obligated
- $11,425.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc., a Rockville, Maryland-based specialty pharmaceutical manufacturer, was awarded a $11,425.69 firm-fixed-price delivery order by Veterans Integrated Service Network 6 (VISN 6) on March 10, 2022, with an ultimate completion date of March 23, 2022. The delivery order, issued without set-aside designation, is for medication to be delivered to Potomac, Maryland, and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This award represents a task order issued against Otsuka's larger Blanket Purchase Agreement with the Department of Veterans Affairs' National Acquisition Center, which carries a ceiling value of $83.3 million and extends through March 26, 2026.
Otsuka America Pharmaceutical Inc. has established itself as a critical supplier of specialized pharmaceuticals to the VA healthcare system, with a particular focus on Jynarque (tolvaptan), a medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The company's portfolio includes a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, enabling it to fulfill delivery orders across multiple Veterans Integrated Service Networks nationwide. This delivery order supports the VA's mission of providing specialized pharmaceutical treatments to veterans, with the company operating as a corporate entity registered in the System for Award Management (SAM) and maintaining consistent firm-fixed-price contracting relationships with the federal healthcare system.
Quick answers
Who was awarded contract 36C24622N0542?
36C24622N0542 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on March 10, 2022.
How much is contract 36C24622N0542 worth?
The government has obligated $11,426 on 36C24622N0542.
Is contract 36C24622N0542 an order under another contract?
Yes. 36C24622N0542 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0542 competed?
The extent of competition for 36C24622N0542 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award